Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Premalignant epidermal changes due to argon laser

R A Neumann

    Lancet (London, England)
    |January 14, 1989
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Results and tissue healing after copper-vapour laser (at 578 nm) treatment of port wine stains and facial telangiectasias.

    The British journal of dermatology·1993
    Same author

    Comparative histochemistry of port-wine stains after copper vapor laser (578 nm) and argon laser treatment.

    The Journal of investigative dermatology·1992
    Same author

    Accurate histochemical definition of argon-laser-induced tissue necrosis.

    Dermatology (Basel, Switzerland)·1992
    Same author

    Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin.

    Journal of the American Academy of Dermatology·1991
    Same author

    Abnormal epidermal changes after argon laser treatment.

    Journal of the American Academy of Dermatology·1991
    Same author

    Photoelectric quantitative evaluation of argon laser treatment of port wine stains.

    The British journal of dermatology·1991
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles